Marie Mainguy
Overview
Explore the profile of Marie Mainguy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mainguy M, Casey R, Vukusic S, Lebrun-Frenay C, Berger E, Kerbrat A, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Feb;
12(2):e200371.
PMID: 39933125
Background And Objectives: Older studies reported an increased risk of relapse after in vitro fertilization (IVF) in women with multiple sclerosis (MS), which has not been confirmed by more recent...
2.
Istvan M, Bresdin V, Mainguy M, Laigo P, Grall-Bronnec M, Eudeline V, et al.
Harm Reduct J
. 2023 Mar;
20(1):43.
PMID: 36991395
Background: Illicit substance use has constantly evolved over the years, particularly in the party scene. Monitoring these changes is essential to adapt harm reduction strategies. The OCTOPUS survey was implemented...
3.
Mainguy M, Le Page E, Michel L, Leray E
Front Neurol
. 2023 Mar;
14:1129117.
PMID: 36873453
Introduction: Many studies have investigated pregnancy in women with multiple sclerosis (MS). However, no study has measured prenatal healthcare utilization in women with MS or adherence to follow-up recommendations to...
4.
Mainguy M, Tillaut H, Degremont A, Le Page E, Mainguy C, Duros S, et al.
Neurology
. 2022 Aug;
99(17):e1916-e1925.
PMID: 35953288
Background And Objectives: Several studies have shown an increased risk of relapse after in vitro fertilization (IVF) in women with multiple sclerosis (MS), especially when a gonadotrophin-releasing hormone (GnRH) agonist...
5.
Laforgue E, Istvan M, Schreck B, Mainguy M, Jolliet P, Grall-Bronnec M, et al.
J Clin Med
. 2022 Apr;
11(8).
PMID: 35456269
Background: To “limit the risk of abuse and misuse” and “encourage correct usage”, the French drug regulatory authority stated that—from April 2017—zolpidem prescription must be performed on a secured prescription...